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1. Introduction 
Enterotoxigenic S. aureus is a major bacterial pathogen that develops multi-drug resistance 
to antibiotics (Pereira et al., 2009; Pu et al., 2011; Rhee & Woo, 2010). The enterotoxigenic 
bacteria and secreted toxins have been reported to cause clinical infections, and it has also 
been reported that they contaminate a broad variety of foods, including breaded chicken 
products (Pepe et al., 2006), canned mushrooms (Anderson et al., 1996), cheeses (Ertas et 
al., 2010; Ostyn et al., 2010; Rosengren et al., 2010), raw milk (Fusco et al., 2011; Heidinger 
et al., 2009), pork meat (Wallin-Carlquist et al., 2010), and other foods (Balaban & Rasooly, 
2000) as well contaminating handles of shopping carts (Mizumachi et al., 2011) causing 
many foodborne illnesses in the United States each year (Shinefield & Ruff, 2009). 
Staphylococcal food poisoning is due to the absorption from the digestive tract into the 
circulation of the enterotoxins preformed in food A toxin level of <1 µg may induce 
symptoms of food poisoning. This level is reached with a bacterial population of >105 
CFU/g food (Stewart, 2005). 
S. aureus produces the virulent staphylococcal enterotoxin A (SEA), a single chain protein that 
consists of 233 amino acid residues with a molecular weight of 27,078 Da. It has been estimated 
that staphylococcal enterotoxin A (SEA) secreted by the bacteria is associated with 78% of 
staphylococcal outbreaks (Vernozy-Rozand et al., 2004). Heat used to eliminate the pathogenic 
bacteria may not eliminate toxins already formed (Margosch et al., 2005; Pepe et al., 2006).  
Staphylococcus enterotoxins (SEs) exhibit two separate biological activities: they cause 
gastroenteritis in the gastrointestinal tract and they act as a superantigen on the immune 
system. Previous research has shown that emetic activities and superantigenic activities of 
SEs are related (Shinefield & Ruff, 2009; Stewart, 2005).  
Because SEA is present in contaminated foods and exerts adverse effects on the 
gastrointestinal tract, there is a need to find food-compatible safe conditions to inactivate it. 
Efforts to inhibit the toxin or its release from S. aureus include the use of electrolyzed water 
(Suzuki et al., 2002), high pressure and heat (Margosch et al., 2005), radiation and pulsed 
electric fields (Walkling-Ribeiro et al., 2008), condensed tannins (Choi et al., 2007) and other 
plant extracts (Carlos et al., 2010; Ifesan & Voravuthlkunchai, 2009), peptides (Wang et al., 
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2008), phenolic compounds (Rúa et al., 2010), licochalcone A (Qiu et al., 2010), essential oils 
(de Souza et al., 2010; Friedman et al., 2004a; Nuñez et al., 2007; Parsaeimehr et al., 2010; Qiu 
et al., 2011), and toxin-specific antibodies (Larkin et al., 2010).  
The objective of our research effort is to discover food-compatible ways to inhibit or 
inactivate both the pathogen and the toxin. In this chapter we will briefly summarize our 
finding in these two areas that are also relevant to atopic dermatitis.  
2. Experimental procedures 
The following experimental methods were used to create the data shown in the Tables and 
Figures. 
2.1 Antibacterial activities of plant compounds against antibiotic-resistant S. aureus 
The following procedure was adapted from Friedman et al. (2004b). Stock suspensions, 1 
mg/mL, of cinnamon oil, oregano oil, thyme oil, carvacrol, and perillaldehyde were 
prepared by vigorous vortexing in phosphate-saline buffer at pH 7. Dilutions from stock 
solutions were revortexed, to ensure even mixing, before being further diluted or added to 
the cell suspension in the microtiter plate. The two solids (β-resorcylic acid and dopamine) 
formed clear solutions in the buffer. Each test substance was prepared fresh before use. 
Individual wells of a microtiter plate (Becton Dickinson, Oxford, UK) were filled with 100 
ml of the test substance in phosphate-saline buffer and 50 ml of the culture. Triplicate wells 
were used for each concentration, with phosphate-saline used in the blank. The plates were 
shaken and then incubated at 37 °C for 1 h. The number of organisms remaining viable was 
then determined by a Nutrient Agar Spread Plate Technique on a 10-ml aliquot removed 
from each well. Plates were incubated overnight at 37 °C prior to counting.  
2.2 Antibacterial activity of Phloxine B against S. aureus 
The following procedure was adapted from Rasooly (2005). Bacteria (200 μL) grown in BHI 
broth were removed during the logarithmic growth phase (OD of 0.3 at 600 nm) and spread 
over the surface of a BHI agar plate with a bent glass rod. Various concentrations of 
Phloxine B (10, 5, 2.5, 1.25 and 0.62 μg) and 5 μg of chloramphenicol (10 units) and 1.5 μg of 
tetracycline (2.5 units) were added to the wells of these plates as antibiotic standards. Plates 
were then incubated for 16 h at 37 °C in the light and in the dark. The potency of Phloxine B 
was determined by measuring the diameter of the inhibition zone made compared to zone 
produced by the standard antibiotics.  
2.3 Antibacterial activity of 4-hydroxytyrosol and Hidrox-12 against S. aureus 
The procedure was adapted from Friedman et al. (2011). S. aureus bacteria were grown 
overnight at 37 °C under aerobic conditions maintained by shaking at 200 rpm in Lucia-
Bertani agar (LB) medium. The effect of 4-hydroxytyrosol and Hidrox-12 on bacterial 
growth was studied by addition of a bacterial suspension (~104 diluted from ~108 
bacteria/mL) to various concentrations of 4-hydroxytyrosol (range: 0.71-0.022 mg/mL) and 
Hidrox-12 suspension (range: 1.29-0.040 mg/mL) in phosphate buffer pH 7.0. After 60 
minutes of incubation at 37 °C, 200 rpm, each dose/bacterial suspension was diluted 1/10 
and then 20 μL of each dose/bacterial suspension were dropped at the top of a square LB 
plate with grids. The plates were tilted and the drops ran down the plate. The plates were 
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dried (~10-15 min) and then incubated overnight 37 °C. Each dose was sampled in 
quadruplicate with control values ~100 colony forming units (CFUs).  
2.4 Prophylactic vaccination of mice with S. aureus 
The following procedure was adapted from Balaban et al. (1998). RAP (regulatory RNAIII 
activating protein, 10 μg) was injected with CFA (completer Freund’s adjuvant) on first 
injection, followed with ICFA (incomplete Freund’s adjuvant) on second and third injections 
subcutaneously into 4-week old immunocompetent hairless male mice on days 0, 7, and 21. 
Control mice were either injected with the adjuvant alone or not injected. Vaccinated and 
control mice were challenged on day 31 with 1.24 x 108 CFU of wild-type Smith diffuse 
strain (SD) of S. aureus subcutaneously together with 1 mg of Cytodex beads to induce local 
infection. The size of the lesion was measured daily. Fisher’s exact probability test was used 
to compare proportions of mice developing lesions and mice developing RAP antibodies 
among the RAP vaccinated, CFA controls, and untreated control groups. Among animals 
that developed lesions after challenge with S. aureus, the size of the lesions was compared by 
single-factor analysis of variance. Post-hoc testing was done by Fisher’s protected least 
significant difference. 
2.5 Staphylococcus enterotoxin (SEA) activity assays  
The procedure was adapted from Friedman et al. (2011). Spleen cells were placed in 96-well 
plates (1 X 106/mL, 0.2 mL) in Russ-10 medium and treated with various concentrations of 
SEA following incubation at 37 °C in a 5% CO2 incubator. After incubation at various time 
points, cell proliferation was measured by adding bromodeoxyuridine (5-bromo-2-
deoxyuridine, BrdU)-labeled DNA to each well 4 h before fixation as described by the 
instructions of the manufacturer. Spectroscopic measurements were made at 620 and 450 nm.  
A second measure of inhibition activity of SEA activity was determined by an enzyme 
cleavage assay. Briefly, the glycyl-phenylalanyl-aminofluorocoumarin (GF-AFC) substrate 
(50 μL) was added to the wells. After mixing and incubation for 30 min at 37°C, this 
substrate enters intact cells. The live cell protease then cleaves GF-AFC, releasing AFC 
which generates a fluorescent signal. The resulting fluorescence was measured by a 
fluorescence plate reader (excitation at 355 nm and emission at 523 nm). We used 5 and 200 
ng/mL of the toxin because at (a) < 5 ng/mL we did not detect cell proliferation induced by 
the toxin; and (b) at ~200 ng/mL proliferation of spleen cells reach a maximum. Results are 
expressed as representative data from triplicate wells from two different methods, BRDU 
and the enzyme cleavage GFA-AFC assays which work only with live cells. 
3. Results and discussion 
Here, we briefly describe our studies designed to demonstrate the potential of bioactive 
food ingredients to inhibit growth of S. aureus bacteria and to inactivate SEA produced by 
these bacteria. The results suggest that it may possible to reduce the toxic potential of these 
toxin-producing organisms with the aid of edible food ingredients.  
3.1 Naturally occurring compounds inactivate antibiotic-resistant Staphylococcus 
aureus 
Antibiotic resistant microorganisms often arise from the administration of sub-therapeutic 
levels of antibiotics in animal feeds. They are present in the animal waste, often 
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contaminating groundwater, surface water, irrigation water, fruits, and vegetables. They can 
then disseminate through the food chain and enter the human intestinal tract after the 
produce or undercooked meat is eaten (Davis & Lederberg, 2001; Walsh, 2003).  
We showed that the following natural substances have antibacterial activity against three 
resistant pathogens including Staphylococcus aureus (ATCC12715): cinnamon oil, oregano 
oil, thyme oil, carvacrol, (S)-perillaldehyde, 3,4-dihydroxybenzoic acid (ǃ-resorcylic acid), 
and 3,4-dihydroxyphenethylamine (dopamine) (Friedman et al., 2004a). Exposure of 
pathogens to a dilution series of the test compounds revealed that oregano oil is the most 
active substance (Table 1). Activities of the test compounds were in the following 
approximate order: oregano oil > thyme oil ≈ carvacrol > cinnamon oil > perillaldehyde > 
dopamine > ǃ-resorcylic acid. The order of susceptibilities of the pathogens to inactivation 
is: B. cereus (vegetative) >> S. aureus ≈ E. coli >> B. cereus (spores). Some of the test 
substances may be effective against antibiotic-resistant bacteria in foods and feeds and in 
hospital environments. 
 
 Concentration in well (μg/ml) 
Compound 0 (control) 66.7 6.67 1.34 0.067 
Oregano oil 4.6 ± 0.081 <1.5 3.4 ± 0.12c 4.6 ± 0.07ab 4.6 ± 0.12b 
Thyme oil 4.6 ± 0.04 <1.5 4.5 ± 0.04b 4.6 ± 0.09b 4.6 ± 0.05b 
Cinnamon oil 4.6 ± 0.12 2.6 ± 0.58 4.6 ± 0.02b 4.6 ± 0.07b 4.7 ± 0.11ab 
Carvacrol 4.9 ± 0.12 0 ± 0 4.8 ± 0.21a 4.8 ± 0.04a 4.8 ± 0.12a 
Perillaldehyde 4.7 ± 0.05 4.1 ± 0.1 4.6 ± 0.11b 4.6 ± 0.12b 4.8 ± 0.02a 
 Concentration in well (μg/ml) 
 0 (control) 3330 670 330 67 
Dopamine 4.6 ± 0.07 3.2 ± 0.33 4.5 ± 0.03 4.5 ± 0.11 4.6 ± 0.12 
 Concentration in well (μg/ml) 
 Control 6000 5330 4670 3330 
ǃ-Resorcylic acid 4.8 ± 0.06 <1.5 <1.5 <1.5 4.6 ± 0.03 
Table 1. Antibacterial activities of three plant essential oils (oregano, thyme, cinnamon), two 
essential oil compounds (carvacrol, perillaldehyde), dopamine, and the phenolic compound 
ǃ-resorcylic acid) against antibiotic-resistant S. aureus (log CFU/ml; average ± SD, n=3). 
CFU = colony-forming-units or bacterial counts. Superscript letters not in common are not 
significantly different (p<0.05). Adapted from (Friedman et al. 2004a). 
3.2 The food dye Phloxine B inactivates S. aureus 
The dye Phloxine B has been approved by the Food and Drug Administration (FDA) for 
human consumption. It is used in food, drugs, and cosmetics. We found that Phloxine B 
exhibits strong antimicrobial activities against several pathogenic bacteria including S. 
aureus (Rasooly, 2005). 
The diffusion assay we used to determine bactericidal effects shows that the activity of 
Phloxine B is similar to that of the medicinal antibiotics chloramphenicol and tetracycline 
(Figure 1). Figure 2 shows the dose-dependence of the inactivation in the range 25 to 100 
μg/ml. A postulated mechanism of antimicrobial effects of the negatively charged dye is 
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described in some detail in the legend of Figure 3. It is likely that related charged 
polyaromatic compounds, including naturally occurring polyphenolic compounds, may 
operate by similar mechanisms. The results suggest that Phloxine B has the potential to be 
used as an antimicrobial agent against S. aureus in pathogens and in veterinary and human 
medicine and against other pathogenic bacteria. Its possible use against atopic dermatitis in 
human patients merits study. 
 
 
 
 
Fig. 1. Antibiotic potency of Phloxine B was determined by agar diffusion assay. Various 
concentrations of Phloxine B (10, 5, 2.5, 1.25, 0.62 µg) and 5 μg of chloramphenicol (10 units) 
and 1.5 μg tetracycline (2.5 units) were added to agar plates seeded with S. aureus (a), or B. 
cereus (b). Following incubation, the plates were examined for bacterial growth inhibition. 
Asdapted from (Rasooly, 2005). 
 
 
 
 
Fig. 2. Dose and time effect of Phloxine B (D&C Red#28) on S. aureus. Mid-log phase culture 
of S. aureus incubated with various concentrations of the dye. Turbidity of the media and 
bacteria viable cell count was measured at 20-minute intervals. Adapted from (Rasooly, 
2005). 
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Fig. 3. The proposed mechanism of antimicrobial effects of the dye Phloxine B. Phloxine B 
(a) is ionized in water and (b) becomes negatively charged. The negatively charged anion (b) 
has a strong affinity for the positively charged cellular components such as proteins. Upon 
illumination (c), the photosensitized Phloxine B gains the energy associated with this light 
causing debromination and formation of free radicals and singlet oxygen (1O2) (d), which 
reacts with bacterial biomolecules (e), leading to cell death of the Gram-positive bacteria. 
The Gram-negative bacteria (f), which have highly negatively charged cell surfaces, repel 
the Phloxine B. Therefore, there is no binding and no antimicrobial effect between the dye 
and the Gram-negative bacteria. In the presence of EDTA, cell permeability increases, 
enabling dye penetration, leading to cell death. Adapted from (Rasooly, 2005). 
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3.3 Inhibition of SEA Release from S. aureus via autoinduction of virulence as a target 
for vaccine and therapy 
With the increase in antibiotic resistance among staphylococci, there is an urgent need to 
develop vaccines to control bacterial infections. Although there are currently several 
vaccines at different stages of clinical development (Broughan et al., 2011), it seems that the 
development of a practical vaccine for which immunological responses can be monitored, 
thus enabling the prediction of its effectiveness in humans, is quite a challenging objective, 
not yet realized.  
We believe that following novel approach we proposed merits further study (Balaban et al., 
1998). The suggested approach is to interfere directly with bacterial virulence by interfering 
with transduction that leads to the production of toxins. This approach offers the possibility 
of transforming a toxin-producing pathogen to a non-pathogenic organism.  
Antibiotic therapy against S. aureus is an important component of treatment for atopic 
dermatitis. However, the emergence of methicillin-resistant S. aureus (MRSA) presents new 
therapeutic challenges that suggest the need to develop new antimicrobial drugs and 
vaccines as an important objective. As mentioned earlier, the pathogenic effects of S. aureus 
are largely due to the production of bacterial toxins, especially SEA, which is regulated by 
the RNA molecule, RNAIII. The S. aureus protein called RAP activates RNAIII, and a 
peptide called RIP produced by non-pathogenic bacteria inhibits RNAIII. We discovered 
that mice vaccinated with RAP or treated with purified or synthetic RIP were protected 
against pathologic effects induced by S. aureus. (Table 2; Figure 4).  
 
Treatment group 
No. of 
mice 
No lesions Lesions Death 
  n (%) N
Mean size 
(mm2) 
n (%) 
Vaccination with RAP as an 
antigen        
RAP 24 17 (71) 6 96 1 (4) 
RAP* 9 7 (78) 2 84 0 (0) 
CFA 10 3 (30) 5 177 2 (20) 
Untreated 12 0 (0) 9 370 3 (25) 
RIP suppression of 8.5 × 107SD        
SD+RIP 4 3 (75) 1 33 0 (0) 
SD+saline 4 1 (25) 3 39 0 (0) 
RIP suppression of 1.4 × 108SD        
SD+RIP 8 4 (50) 4 45 0 (0) 
SD+saline 6 0 (0) 6 100 0 (0) 
RIP and Pep suppression of  
1.4 × 109SD        
SD+RIP 10 3 (30) 3 39 4 (40) 
SD+saline 10 2 (20) 6 160 2 (20) 
SD+Pep 10 9 (90) 1 56 0 (0) 
SD+DMSO 9 2 (20) 4 128 3 (22) 
Table 2. Vaccination or suppression of S. aureus SD infections. Adapted from (Balaban et 
al., 1998). 
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Fig. 4. Inhibition of RNAIII by native and synthetic RIP. Increasing amounts of RIP, which 
was purified on a C18 column or increasing amounts of synthetic peptide (Pep) were added 
to early exponential wild-type S. aureus and tested for the ability to inhibit RNAIII. Density 
of RNAIII is shown. p<0.05. Adapted from (Balaban et al., 1998). 
Experimentally, we found that when we used increased inoculums of bacteria (1.4 × 108 cells 
per injection), four of eight animals were protected, and the remaining four developed a 
lesion that was 55% smaller than in control animals (Table 2). All the control animals (seven 
out of seven) challenged with SD and saline developed a lesion. When more bacteria were 
used (1.4 × 10), the synthetic RIP (0.5 mg of Pep) protected animals—90% (9 out of 10) of the 
animals showed no sign of disease (Table 2). These results suggest that the ratio between 
RIP and the bacteria is critical and helps determine the success of the host's immune 
response to eliminate the bacteria. 
These observations suggest that targeting autoinducers of virulence or the signal 
transduction they activate may, therefore, be a unique and useful approach in preventing 
pathogenesis of toxin-producing S. aureus and possibly other toxin-producing pathogenic 
bacteria. 
3.4 Apple polyphenols inhibit T-helper cell proliferation and cytokine production in 
spleen cells from C57BL/6 female mice 
As mentioned earlier, S. aureus is a major bacterial pathogen that causes clinical infection 
and food-borne illnesses (Dinges et al., 2000). This bacterium produces a group of twenty-
one known enterotoxins (SEs) that have two separate biological activities: they cause 
gastroenteritis in the gastrointestinal tract and act as a superantigen on the immune system. 
Functional enterotoxins bind to the alpha-helical regions of the major histocompatibility 
complex (MHC) class II molecules outside the peptide-binding groove of the antigen 
presenting cells (APC), and also to the variable region (Vß) on T-cell receptors. The toxin 
then forms a bridge between T cells and APCs. This event then initiates the proliferation of a 
large number (~20%) of T cells that induce the release of cytokines. At high concentrations, 
cytokines are involved in the etiology (causes) of several known human and animal 
diseases. These include atopic dermatitis and rheumatoid arthritis in humans (Lin et al., 
2011; MacIas et al., 2011; Yeung et al., 2011).  
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Atopic dermatitis (eczema) is an inflammatory skin disease that affects 10-20% of children 
and 1-3% of adults (1-3). Antibiotics that suppress colonization of S. aureus are reported to 
mitigate the severity of atopic dermatitis disease. Most strains of S. aureus isolated from 
atopic skin lesions produce exotoxins with superantigen properties (Leung et al., 1993). It 
has been reported that staphylococcal superantigens can induce skin inflammation by 
several different mechanisms (Taskapan & Kumar, 2000). The reason we selected the 
superantigen for this study is that it is has been demonstrated to be an aggravating factor in 
atopic dermatitis, and because SEA is a representative antigen. 
It has been previously reported that consumption of apple condensed tannins from unripe 
apples improve the symptoms associated with atopic dermatitis (Kojima et al., 2000). The 
mechanism of this improvement is largely unknown.  
The main objective of our study was therefore to determine whether the beneficial effect of 
apple polyphenols is due to binding and inhibition of the superantigen and/or to inhibition 
of cell proliferation. 
In the present study, we evaluated the ability of one commercial and two freshly prepared 
apple juices and of a commercial apple polyphenol preparation (Apple Poly®) to inhibit the 
biological activity of SEA. The results are depicted in Figures 5-9. Dilutions of freshly 
prepared apple juices and of Apple Poly® inhibited the biological activity of SEA without 
any significant cytotoxic effect on the spleen cells. Additional studies with antibody-coated 
immunomagnetic beads bearing specific antibodies against the toxin revealed that SEA 
added to apple juice appears to be largely irreversibly bound to the juice constituents (Fig. 
8). The results suggest that food-compatible and safe anti-toxin phenolic compounds can be 
used to inactivate SEA in vitro and possibly also in vivo, even after the induction of T-cell 
proliferation by long-term exposure to SEA. The significance of the results for microbial 
food safety and human health is discussed.  
 
 
 
 
Fig. 5. Effect of apple juice on splenocyte proliferation. Apple juice and media used as a 
control with or without SEA (1 ng/mL) were incubated for 48 h with splenocyte cells 
followed by determining newly synthesized DNA (A) by cleavage of the peptide GF-AFC 
and (B) by use of live splenocytes. Error bars (n = 3) represent standard errors. Adapted 
from (Rasooly et al., 2010). 
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Fig. 6. Red Delicious apple juice inhibits high SEA concentrations. Three concentrations of 
SEA were incubated for 48 h with splenocyte cells followed by determining newly 
synthesized DNA. Error bars (n = 3) represent standard errors. Adapted from (Rasooly et al. 
2010). 
 
 
 
 
 
 
Fig. 7. Red Delicious apple juice reduces the activity of SEA after 24 or 48 h of incubation. 
Different amounts of SEA were added to the splenocytes, which were then incubated for 24 
or 48 h. This was followed by the addition of Red Delicious apple juice and the 
determination of biological activity by cleavage of GF-AFC, produced by the live splenocyte 
cells after (A) 48 h or (B) 72 h. Error bars (n = 3) represent standard errors. Adapted from 
(Rasooly et al., 2010). 
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These observations suggest that Red Delicious juice has an inhibitory effect even after cell 
proliferation was initiated. We suggest that components of the juice disrupt the connection 
between antigen presenting cells (APCs) and T cells. Our results also imply that the 
mechanism by which consumed apple juice or apples may decrease the symptoms 
associated with atopic dermatitis is via inhibition of proliferation of T cells and the release of 
cytokines. The postulated mechanism that may govern the inhibition of the biological 
activity of SEA by apple compounds is visually illustrated in Figure 9.  
 
 
 
 
 
 
 
Fig. 8. Extraction and elution of SEA from apple juice treated with immunomagnetic beads. 
Apple juices were spiked with SEA (1 ng/mL) and incubated for 16 h with immunomagnetic 
beads. The toxin was dissociated from the beads and incubated with spleen cells. This was 
followed by the determination of newly synthesized DNA. Error bars (n = 3) represent 
standard errors. These results indicate that SEA added to apple juice appears to be largely 
irreversibly bound to the juice constituents. Adapted from (Rasooly et al. 2010). 
The described findings suggest that apple juices and polyphenol-rich apple skin extracts 
have the potential to counteract adverse effects in animals and humans induced by SEA, and 
possibly also by the foodborne pathogen S. aureus that produces this virulent toxin. It would 
be of interest to find out whether or not the inhibited toxin in apple juice is reactivated in the 
digestive tracts of animals and humans and whether or not phenolic compounds present in 
other juices can concurrently inhibit the growth of S. aureus and other pathogens and the 
toxins produced by the pathogens.  
In summary, our studies with apple juice and apples skin extracts demonstrated that apple 
polyphenols strongly inhibited superantigen-induced T-cell proliferation and cytokine 
production. The results also indicate that the low inhibitory action of freshly prepared Red 
Delicious apple juice is enhanced by added apple polyphenols. Further studies are needed 
to determine whether or not this combination may protect against animal and human 
diseases induced by high cytokine levels. 
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Fig. 9. A schematic representation of cellular events that lead to the inhibition of SEA-
induced cell proliferation by apple juice. The individual steps in this scheme involve the (A) 
the formation of a bridge between APCs and T cells which results in induction of T-cell 
proliferation and (B) inhibition of T-cell proliferation by added pure apple juice that 
disrupts the connection between APCs and T cells. The net beneficial result of these events is 
the prevention of release and the consequent adverse effects induced by cytokines described 
in the Introduction. Abbreviations: MHC, major histocompatibility complex; TCR, T-cell 
receptor. Adapted from (Rasooly et al., 2010). 
 
 
Fig. 10. Structure of the olive compound, hydroxytyrosol that inhibits S. aureus and SEA. 
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3.5 The olive compound 4-hydroxytyrosol inactivates both S. aureus and inhibits the 
biological activity of SEA 
Our observations that dilutions of freshly prepared apple juices and of a commercial apple 
skin preparation inhibited the biological activity of SEA in a spleen cell assay suggested that 
other natural plant-derived compounds and plant extracts have the potential to inhibit the 
growth of foodborne pathogens and the toxicological effects of toxins produced by some 
pathogens (Rasooly et al., 2010).  
To further demonstrate this possibility, the objectives of another study were to determine 
whether the pure olive compound hydroxytyrosol (Figure 12) and a commercial olive 
powder named Hidrox-12 that contains hydroxytyrosol can inactivate S. aureus bacteria and 
inhibit the biological activity of SEA (Friedman et al., 2011). We found that olive ingredients 
also posses anti-S. aureus activity that reduced the counts of the bacteria in a dose-
dependent manner. With hydroxytyrosol, the viable count of S. aureus bacteria after 
treatment at a concentration of 0.67 mg/ml for 60 min of contact, determined by plating on 
LB agar media, was decreased by 85%. We also found that dilutions of both test substances 
inactivated the pathogens.  
 
 
Fig. 11. Effect of hydroxytyrosol on splenocyte proliferation determined by two 
independent methods. Different concentrations of the toxin (0, 5, and 200 ng/mL) were 
exposed to hydroxytyrosol or the control (media) and were then incubated for 48 h with 
splenocyte cells followed by determining (A) GF-AFC cleavage by live cell protease (a 
measure of cellular activity) or (B) BrdU incorporation into newly synthesized DNA (a 
measure of cellular proliferation). Conditions: (A) GF-AFC substrate in intact cells is 
cleaved by live cell protease releasing the fluorescent AFC, quantified at an excitation 
wavelength of 355 nm and an emission wavelength of 523 nm. (B) BrdU (5-bromo-2-
deoxyyridine)-labeled DNA was determined spectrophotometrically at absorbances of 620 
nm and 450 nm. Error bars (n = 3) represent standard errors. Both assays show that 
hydroxytyrosol inhibited the biological activity of SEA. Error bars represent standard 
error (SEs), and an asterisk indicates significant differences (P<0.05) between treatments. 
Adapted from (Friedman et al., 2011). 
Two independent cell assays (BrdU incorporation into newly synthesized DNA and glycyl-
phenylalanyl-aminofluorocoumarin (GF-AFC) proteolysis) demonstrated that the olive 
compound also inhibits the biological activity of SEA. The described findings suggest that 
olive compounds have the potential to counteract adverse effects induced by SEA and by 
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the foodborne pathogen S. aureus that produces this virulent toxin. To our knowledge, this is 
the first report that demonstrated with the aid of bactericidal and cell assays that the edible 
olive compound hydroxytyrosol can inactivate both S. aureus bacteria and SEA. The results 
suggest that food-compatible and safe anti-toxin olive compounds merit further study 
designed to demonstrate their potential to treat atopic dermatitis. 
It would be of interest to extend these studies to the inactivation of other pathogens and 
toxins such as E. coli and Shiga toxin in vitro and in contaminated food such as meat, milk, 
and leafy greens. 
 
 
Fig. 12. (A) Antimicrobial activity of hydroxytyrosol against S. aureus. Conditions: bacteria 
were incubated with different concentrations of hydroxytyrosol. After incubation for 60 min, 
cells were plated and bacteria counted. (B) Antimicrobial activity of Hidrox-12 against S. 
aureus. Conditions: similar to those used for hydroxytyrosol. Error bars represent standard 
errors (n = 4). Both the pure olive compound and the olive extract inhibited the bacteria. The 
extent of inhibition by the extract was approximately equivalent to its content (12%) of 
hydroxytyrosol. Adapted from (Friedman et al. 2011). 
4. Conclusion 
S. aureus is a major bacterial pathogen that develops resistance to medical antibiotics. It 
has been reported to cause clinical infections and contamination of a broad variety of 
foods that may result in foodborne illness. These include canned mushroom, breaded 
chicken products, cheese, and raw milk as well on handles of shopping carts causing 185 
000 cases of foodborne illnesses in the United States each year. S. aureus bacteria are 
present on the skin patients with atopic dermatitis. Many strains of S. aureus isolated from 
atopic skin lesions produce enterotoxins with superantigenic properties. S. aureus 
produces the virulent staphylococcal enterotoxin A, a single chain protein that consists of 
233 amino acid residues. It has been estimated that the toxin that is secreted by the 
bacteria is associated with 78% of staphylococcal outbreaks. Our studies show that 
naturally occurring edible apple phenolic and olive compounds can both inactivate 
S. aureus bacteria and reduce the biological/toxicological properties of the toxin produced 
by these bacteria and that the food dye Phloxine B inhibits the release of SEA from the 
pathogens. Whether these novel approaches have therapeutic potential against atopic 
dermatitis and other diseases merits further study. 
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The described studies are part of a broader effort, the specific objective of which is to 
transform toxic proteins to nontoxic, digestible proteins in foods. For example, apple and 
other polyphenols present in numerous plant foods such as teas, sweet potatoes, and jujube 
fruits and seeds contain electron-rich aromatic structures and ionizable phenolic OH groups. 
These structures can in theory change the toxin via non-covalent binding to the toxin and/or 
by altering the distribution of ionic charges via H-bonding between OH groups and 
ionizable groups of the protein. We have no direct evidence for this theory, but note that in 
molecular simulation studies, we observed multiple hydrogen-bonding interactions 
between polyphenolic tea catechins and cell membranes that may result in anti-bactericidal 
effects due to disruption of the cell membranes followed by cell death (Sirk et al., 2009; Sirk 
et al., 2008; Sirk et al., 2011). 
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